December 18, 2017 - For the fourth year in a row, the Holden Cancer Center’s BMT Program was rated an “over-performer” by the Center for International Blood & Marrow Transplant Research (CIBMTR) in their annual review and ranking.
December 12, 2017 - Dr. Warren Schmidt has been awarded a four-year, $625,000 VA Merit grant to study the influence of Hepatitis C virus on the cellular enzyme telomerase.